search

Active clinical trials for "Hemorrhage"

Results 2831-2840 of 2870

Computed Tomography in Gastrointestinal Bleeding

Gastrointestinal Bleeding

Gastrointestinal bleeding represents a serious clinical problem and a common cause of hospitalisation with a mortality rate of 6-10% for upper Gastrointestinal bleeding and of 4% for lower Gastrointestinal bleeding requires a multidisciplinary approach involving gastroenterologists, endoscopists, surgeons and radiologists. Gastrointestinal bleeding is self-limited in 80% of cases requiring only supportive measures. However, the persistence of bleeding represents a diagnostic challenge to locate the site of bleeding especially in severe bleeding and to determine, if possible its cause. This will allow to select the most appropriate therapeutic approach in order to reduce the morbidity and mortality, the length of hospitalisation and the transfusion requirements. Current diagnostic algorithms vary widely from institution to institution and from clinician to clinician. Imaging modalities remain the mainstay of the diagnostic approach. They include endoscopy, video capsule, radionuclide imaging, catheter angiography and multidetector computed tomography imaging. In recent years, Multidetector computed tomography has emerged as a promising technology to evaluate Gastrointestinal bleeding. The modality's ease of use and rapid results favour its use in any emergent situation. In addition, today's high-speed, narrow collimation multi-detector technology allows a large coverage area with minimal motion artifacts, with the ability to capture both arterial and venous phase with ease. Multidetector computed tomography is being increasingly used as this is a widely available, non-invasive and fast diagnostic technique that allows for visualisation of the entire intestinal tract and its lesions, the identification of vascularity and possible vascular abnormalities.

Unknown status2 enrollment criteria

Bedside Assessment of Coagulation in Post-partum Hemorrhage by Thromboelastography (TEG ®6S)

Coagulation Defect; PuerperalPost Partum Hemorrhage2 more

Postpartum hemorrhage (PPH) is one of the leading causes of maternal deaths. Its prognosis is directly influenced by the early diagnosis and treatment of the associated coagulopathy. In this context, fibrinogen concentration is the best predictor of a severe PPH. The medical interest of thromboelastography/elastometry to early detect and guide the rapid correction of coagulopathy in PPH is regularly discussed. The principal aim of this study is to evaluate the performance of a new hemostasis point of care device (thromboelastography - TEG ®6S) for the diagnosis of coagulopathy during PPH. A secondary aim will be to determine the normal values of TEG6S at the end of a normal pregnancy.

Unknown status11 enrollment criteria

A Research on Hidden Blood Loss in Open Radical Hysterectomy and Pelvic Lymphadenectomy

Hidden Blood LossOpen Radical Hysterectomy1 more

The aim of this cross-sectional study is to evaluate the hidden blood loss in patients who underwent open radical hysterectomy and identity its risk factors.

Unknown status7 enrollment criteria

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

Postpartum Hemorrhage

The aim of this study is to evaluate the renal outcome of patients undergoing elective C/S where oxytocin or carbetocin is used for postpartum hemorrhage prophylaxis.

Unknown status7 enrollment criteria

Endometrial Evaluation in Cases of Postmenopausal Bleeding

Postmenopausal Bleeding

The aim of this prospective observational study is to evaluate abnormal uterine bleeding in postmenopausal women using 3D(dimensional) ultrasound assessment of endometrial volume .Doppler assessment of endometrium and hysteroscopy and to correlate this finding with pathological finding of endometrial biopsy

Unknown status6 enrollment criteria

Volatile Organic Compounds (VOCs) of Exhaled Breath in Patients With GI Bleeding

Gastrointestinal HemorrhageVolatile Organic Compounds

Cross sectional case-control study investigating the difference of volatile organic compound in the exhaled breath of the patients with GI bleeding and normal population.

Unknown status7 enrollment criteria

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding

Endometrial NeoplasmsPostmenopause3 more

This study aims to explore the sensitivity of an innovative marker, HE4, in the diagnosis approach of endometrial cancer in case of postmenopausal bleedings.

Unknown status11 enrollment criteria

An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases

StrokeCerebrovascular Diseases4 more

In this protocol, the investigators present methods and preliminary results from the PLATFORM-CVD Study, an EHR-based multicenter cohort. This study will focus on assessing the distribution of major cerebrovascular diseases, determining the risk factors associated with disease incidence and worse in-hospital outcomes, as well as describing the quality of care. Data from this cohort will be used to develop suitable prediction models for cerebrovascular diseases using real-world data and to understand how outcomes for cerebrovascular diseases would change with quality improvement interventions.

Unknown status9 enrollment criteria

Stereotactic Aspiration for Primary Brainstem Hemorrhage Based on 'Zhe-er Classification'

Primary Brainstem Hemorrhage

The purpose of this study is to determine the benefit of stereotaxic aspiration for patients with primary brainstem hemorrhage with the guidance of 'Zhe-er Classification'

Unknown status3 enrollment criteria

Predictors of Intracranial Hemorrhage in ARDS Patients on ECMO

ARDSHuman1 more

Intracranial hemorrhage is is a rare, but critical incident in patients with acute lung failure undergoing ECMO therapy. Predictors of intracranial hemorrhage are yet to be defined to identify patients at (high) risk. This retrospective analysis investigates the predictive value and validity of parameters and specific risk factors of critically ill ARDS patients treated with ECMO.

Unknown status5 enrollment criteria
1...283284285...287

Need Help? Contact our team!


We'll reach out to this number within 24 hrs